PRESS RELEASE published on 05/10/2023 at 14:30, 3 years 5 months ago Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription Drug
PRESS RELEASE published on 05/09/2023 at 14:30, 3 years 5 months ago Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 05/08/2023 at 14:30, 3 years 5 months ago Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
PRESS RELEASE published on 05/05/2023 at 22:15, 3 years 5 months ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 05/01/2023 at 14:30, 3 years 5 months ago Napo Therapeutics Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress in Abu Dhabi
PRESS RELEASE published on 04/27/2023 at 14:30, 3 years 5 months ago U.S. Veterinary Oncologists Participating in a New Survey Prefer Canalevia-CA1 Over the Current Standard of Care
PRESS RELEASE published on 04/11/2023 at 14:30, 3 years 6 months ago Patient Enrollment Surpasses 90% in Jaguar Health's Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 04/06/2023 at 14:30, 3 years 6 months ago Jaguar Health Provides Update on Monitoring Trading Activity to Identify Possible Illegal Short Selling
PRESS RELEASE published on 03/30/2023 at 14:30, 3 years 6 months ago Jaguar Animal Health Exhibiting at Veterinary Cancer Society Collaborative Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 03/27/2023 at 13:00, 3 years 6 months ago Jaguar Health Reports 2022 Financial Results - Prescription Revenues up 179% to $11.9 Million
Published on 10/24/2026 at 00:04, 2 days 8 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 8 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 10 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 16 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/26/2026 at 08:03, 25 minutes ago Verve Group Media SE: Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
Published on 10/26/2026 at 08:03, 25 minutes ago Verve Group Media SE: Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
Published on 10/26/2026 at 08:03, 25 minutes ago Verve Group Media SE: Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
Published on 10/26/2026 at 08:03, 25 minutes ago Verve Group Media SE: Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
Published on 10/26/2026 at 08:03, 25 minutes ago Verve Group Media SE: Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
Published on 10/26/2026 at 07:30, 58 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/23/2026 at 20:33, 2 days 11 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 14 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 14 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
